1. Home
  2. MREO vs ZKH Comparison

MREO vs ZKH Comparison

Compare MREO & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • ZKH
  • Stock Information
  • Founded
  • MREO 2015
  • ZKH 1998
  • Country
  • MREO United Kingdom
  • ZKH China
  • Employees
  • MREO N/A
  • ZKH N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • ZKH
  • Sector
  • MREO Health Care
  • ZKH
  • Exchange
  • MREO Nasdaq
  • ZKH Nasdaq
  • Market Cap
  • MREO 438.8M
  • ZKH 496.1M
  • IPO Year
  • MREO N/A
  • ZKH 2023
  • Fundamental
  • Price
  • MREO $2.87
  • ZKH $3.18
  • Analyst Decision
  • MREO Strong Buy
  • ZKH Buy
  • Analyst Count
  • MREO 5
  • ZKH 1
  • Target Price
  • MREO $7.60
  • ZKH $4.00
  • AVG Volume (30 Days)
  • MREO 1.3M
  • ZKH 21.1K
  • Earning Date
  • MREO 08-12-2025
  • ZKH 08-21-2025
  • Dividend Yield
  • MREO N/A
  • ZKH N/A
  • EPS Growth
  • MREO N/A
  • ZKH N/A
  • EPS
  • MREO N/A
  • ZKH N/A
  • Revenue
  • MREO N/A
  • ZKH $1,217,705,644.00
  • Revenue This Year
  • MREO N/A
  • ZKH $11.72
  • Revenue Next Year
  • MREO $52.34
  • ZKH $10.57
  • P/E Ratio
  • MREO N/A
  • ZKH N/A
  • Revenue Growth
  • MREO N/A
  • ZKH 2.24
  • 52 Week Low
  • MREO $1.58
  • ZKH $2.50
  • 52 Week High
  • MREO $5.02
  • ZKH $4.10
  • Technical
  • Relative Strength Index (RSI)
  • MREO 61.43
  • ZKH 55.53
  • Support Level
  • MREO $2.63
  • ZKH $3.02
  • Resistance Level
  • MREO $2.85
  • ZKH $3.17
  • Average True Range (ATR)
  • MREO 0.16
  • ZKH 0.17
  • MACD
  • MREO -0.01
  • ZKH -0.00
  • Stochastic Oscillator
  • MREO 79.41
  • ZKH 87.14

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

Share on Social Networks: